Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JENNY ZHU YANG

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1346636453
CMS profile
7229182
Location
LA JOLLA, CA

General Payments · PY2019–2024

$27,246.82

  • Reported across 92 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$12,259.66

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme Corporation $11,514.18 18
Actelion Pharmaceuticals US, Inc. $287.01 3
Inari Medical, Inc. $253.00 5
United Therapeutics Corporation $205.47 8

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $172.25 3
PY2020 $115.39 2
PY2021 $154.37 4
PY2022 $1,168.76 19
PY2023 $13,376.39 30
PY2024 $12,259.66 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $125.55 05/21/2024 Food and Beverage Undisputed 01/23/2026 1078871604 CMS
Actelion Pharmaceuticals US, Inc. $130.73 09/03/2024 Food and Beverage Undisputed 01/23/2026 1078871418 CMS
Actelion Pharmaceuticals US, Inc. $30.73 12/17/2024 Food and Beverage Undisputed 01/23/2026 1078871910 CMS
Inari Medical, Inc. $40.09 01/10/2024 Food and Beverage Undisputed 01/23/2026 1140175814 CMS
Inari Medical, Inc. $18.00 01/11/2024 Food and Beverage Undisputed 01/23/2026 1140175816 CMS
Inari Medical, Inc. $121.73 04/15/2024 Food and Beverage Undisputed 01/23/2026 1140175818 CMS
Inari Medical, Inc. $39.27 04/15/2024 Food and Beverage Undisputed 01/23/2026 1140175820 CMS
Inari Medical, Inc. $33.91 11/25/2024 Food and Beverage Undisputed 01/23/2026 1140175822 CMS
Merck Sharp & Dohme LLC $30.78 01/19/2024 Food and Beverage Undisputed 01/23/2026 1141726327 CMS
Merck Sharp & Dohme LLC $16.05 03/07/2024 Food and Beverage Undisputed 01/23/2026 1141726325 CMS
Merck Sharp & Dohme LLC $23.40 04/18/2024 Food and Beverage Undisputed 01/23/2026 1141726323 CMS
Merck Sharp & Dohme LLC $117.56 06/13/2024 Food and Beverage Undisputed 01/23/2026 1141726333 CMS
Merck Sharp & Dohme LLC $27.49 06/29/2024 Food and Beverage Undisputed 01/23/2026 1141726331 CMS
Merck Sharp & Dohme LLC $25.62 07/31/2024 Food and Beverage Undisputed 01/23/2026 1141878131 CMS
Merck Sharp & Dohme LLC $96.97 08/27/2024 Food and Beverage Undisputed 01/23/2026 1141726329 CMS
Merck Sharp & Dohme LLC $304.07 09/19/2024 Travel and Lodging Undisputed 01/23/2026 1141726127 CMS
Merck Sharp & Dohme LLC $269.55 09/19/2024 Travel and Lodging Undisputed 01/23/2026 1141726131 CMS
Merck Sharp & Dohme LLC $155.91 09/19/2024 Travel and Lodging Undisputed 01/23/2026 1141726133 CMS
Merck Sharp & Dohme LLC $331.79 09/19/2024 Travel and Lodging Undisputed 01/23/2026 1141726321 CMS
Merck Sharp & Dohme LLC $59.99 09/20/2024 Food and Beverage Undisputed 01/23/2026 1141726143 CMS
Merck Sharp & Dohme LLC $65.00 09/20/2024 Food and Beverage Undisputed 01/23/2026 1141726145 CMS
Merck Sharp & Dohme LLC $55.00 09/20/2024 Food and Beverage Undisputed 01/23/2026 1141881664 CMS
Merck Sharp & Dohme LLC $25.00 09/25/2024 Travel and Lodging Undisputed 01/23/2026 1141726317 CMS
Merck Sharp & Dohme LLC $4,270.00 09/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1141881666 CMS
Merck Sharp & Dohme LLC $5,490.00 10/07/2024 Consulting Fee Undisputed 01/23/2026 1141726129 CMS
Merck Sharp & Dohme LLC $150.00 10/07/2024 Travel and Lodging Undisputed 01/23/2026 1141726319 CMS
United Therapeutics Corporation $33.69 02/26/2024 Food and Beverage Undisputed 01/23/2026 1149464806 CMS
United Therapeutics Corporation $31.19 03/04/2024 Food and Beverage Undisputed 01/23/2026 1149466258 CMS
United Therapeutics Corporation $17.04 04/24/2024 Food and Beverage Undisputed 01/23/2026 1149447570 CMS
United Therapeutics Corporation $32.97 07/08/2024 Food and Beverage Undisputed 01/23/2026 1149468924 CMS
United Therapeutics Corporation $23.94 08/26/2024 Food and Beverage Undisputed 01/23/2026 1149456070 CMS
United Therapeutics Corporation $25.05 10/07/2024 Food and Beverage Undisputed 01/23/2026 1149457026 CMS
United Therapeutics Corporation $23.26 11/06/2024 Food and Beverage Undisputed 01/23/2026 1149472010 CMS
United Therapeutics Corporation $18.33 11/20/2024 Food and Beverage Undisputed 01/23/2026 1149458904 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.